According to Selecta Biosciences's latest financial reports the company's current earnings (TTM) are -$32.81 M. In 2022 the company made an earning of $37.8 M an increase over its 2021 earnings that were of -$6.88 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$32.81 M | -186.79% |
2022 | $37.8 M | -649.67% |
2021 | -$6.88 M | -89.78% |
2020 | -$67.32 M | 25.06% |
2019 | -$53.84 M | -15.68% |
2018 | -$63.85 M | -0.43% |
2017 | -$64.12 M | 83.41% |
2016 | -$34.96 M | 44.3% |
2015 | -$24.23 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$0.12 B | 237.67% | ๐บ๐ธ USA |